Is it safe?
Can TECH take a bad year?
Bio-Techne holds $9.8M more cash than debt, so a bad year is a question about profits, not about lenders.
$9.8M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 10.04
Altman Z-score · safe zone, above 3
- Interest cover
- 15.9×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ3 2026
- $200M
- Cash and short-term investments
- $210M
- Net cash
- $9.8M
- EBITDA, trailing twelve months
- $236M
- Operating profit, trailing twelve months
- $154M
- Debt / equity
- 0.10×
- Total debt / EBITDA
- 0.85×
- Annualised volatilitytwo years of daily moves
- 46%
- Worst drawdown on file
- −67%
- Below its 52-week high
- −0.17%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.